Streetbeat News

OSCR

Oscar Health, Inc.

https://www.hioscar.com

Industry

Medical - Healthcare Plans

Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

Open

15.53

Mkt cap

3.1B

Volume

6M

High

15.70

P/E Ratio

-743.50

52-wk high

23.79

Low

14.23

Div yield

N/A

52-wk low

7.16

Piper Sandler analyst Jessica Tassan has reiterated an Overweight rating on Oscar Health (NYSE:OSCR) and maintained a price target of $28.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:34 pm

Oscar Health (NYSE:OSCR) has been analyzed by 7 analysts over the past three months, showing a range of perspectives from bullish to bearish. The average 12-month price target has increased by 5.66% to $25.57. Key analysts have adjusted their ratings and price targets, reflecting their views on the company's market performance. Oscar Health has shown strong revenue growth and effective utilization of equity and assets, but faces challenges in maintaining profitability.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 7:04 pm

Oscar Health shares are trading higher after Piper Sandler maintained an Overweight rating on the stock and raised its price target from $25 to $28.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 2:25 pm

Piper Sandler analyst Jessica Tassan maintains an Overweight rating on Oscar Health (NYSE:OSCR) and raises the price target from $25 to $28.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:40 am

Oscar Health shares are trading higher after the company raised its FY24 guidance.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:14 am

Oscar Health has raised its FY24 revenue forecast from $8.3B - $8.4B to $9.0B - $9.1B, surpassing the estimated $8.604B. Additionally, the company has increased its adjusted EBITDA forecast by $35 million, now expecting it to be in the range of $160 million to $210 million.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 10:08 am

Oscar Health has announced that it is well-positioned to achieve its target for adjusted EBITDA profitability this year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 10:06 am

Oscar Health (NYSE:OSCR) reported Q2 2024 earnings per share (EPS) of $0.20, surpassing the analyst consensus estimate of $0.16 by 25%. The company also reported quarterly sales of $2.219 billion, beating the estimate of $2.155 billion by 2.99%. This marks a significant improvement from the same period last year, with EPS increasing by 385.71% and sales by 45.89%.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 10:01 am

Shares of insurance companies are trading lower amid overall weakness following concerns for recently issued US economic data.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 2:49 pm

Shares of companies within the broader financial sector are trading lower amid overall market weakness following weak US jobs data.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 5:05 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.